These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38756632)

  • 21. Integrated Analysis of CD1A Immune Infiltration and Competing Endogenous RNA Networks in COAD.
    Xu H; Zhang H; Sun S; Zhang J; Huo J; Zhou C
    Int J Gen Med; 2024; 17():2037-2053. PubMed ID: 38751492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revealing potential immunotherapy targets through analysis of a ceRNA network in human colon adenocarcinoma.
    Li C; Zhu Z; Hou Q; Wang B; Zou L; Liu L; Gong W; Guo H
    Transl Cancer Res; 2021 Dec; 10(12):5319-5336. PubMed ID: 35116380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma.
    Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A
    Front Oncol; 2022; 12():941156. PubMed ID: 36505813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [High expression of ANKRD6 is an indicator for poor prognosis of colon adenocarcinoma].
    Zhao H; Liu G; Li Y; Yang N; Zhao J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1715-1724. PubMed ID: 37933647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The noncoding RNAs regulating pyroptosis in colon adenocarcinoma were derived from the construction of a ceRNA network and used to develop a prognostic model.
    Chen Y; Tian Z; Hou H; Gai W
    BMC Med Genomics; 2022 Sep; 15(1):201. PubMed ID: 36127676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes.
    Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H
    Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma.
    Zhang J; Wu Y; Mu J; Xin D; Wang L; Fan Y; Zhang S; Xu Y
    Front Oncol; 2022; 12():954226. PubMed ID: 36203430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction.
    Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X
    Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis.
    Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ
    Front Oncol; 2022; 12():1022097. PubMed ID: 36300102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel characterization discoveries of ferroptosis-associated molecules in COAD microenvironment based TCGA data.
    Baldi S; He Y; Ivanov I; Sun Y; Feng W; Refat M; Mohammed SAD; Adlat S; Tian Z; Wang Y; Gao Y; Tian H
    Front Mol Biosci; 2022; 9():1102735. PubMed ID: 36582202
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening of m6A gene-related lncRNAs in colon adenocarcinoma and construction of a prognostic prediction model.
    Jin LP; Sun YW; Liu T; Tai JD
    Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10462-10471. PubMed ID: 37975370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism-Related Prognostic Biomarkers, Purine Metabolism and Anti-Tumor Immunity in Colon Adenocarcinoma.
    Liu H; Zhang Y; Zhang Q; Zhang T; Lu T
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):328. PubMed ID: 38179743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
    Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
    Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma.
    Liu X; Fang X; Lu L; Liu G
    Front Genet; 2022; 13():996625. PubMed ID: 36568396
    [No Abstract]   [Full Text] [Related]  

  • 36. NXPH4 can be used as a biomarker for pan-cancer and promotes colon cancer progression.
    Zhang Z; Wang P; Chen S; Xiang D; Chen J; Huang W; Liu X; Yi T; Wang D; Pu Y; He L; Zhang H
    Aging (Albany NY); 2024 Apr; 16(7):5866-5886. PubMed ID: 38613793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the six-hormone secretion-related gene signature as a prognostic biomarker for colon adenocarcinoma.
    Jia X; Zhang T; Lv X; Du H; Sun Y; Guan Y
    Cancer Biomark; 2023; 38(4):523-535. PubMed ID: 38143338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma.
    Guo Y; Wang Z; Tian Y; Li L; Dong J
    Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear receptor subfamily 3 group c member 2 (NR3C2) is downregulated due to hypermethylation and plays a tumor-suppressive role in colon cancer.
    Li X; Yang A; Wen P; Yuan Y; Xiao Z; Shi H; Wang R
    Mol Cell Biochem; 2022 Nov; 477(11):2669-2679. PubMed ID: 35604518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis.
    Zhang L; Jiang X; Li Y; Fan Q; Li H; Jin L; Li L; Jin Y; Zhang T; Mao Y; Hua D
    Front Oncol; 2020; 10():1504. PubMed ID: 32983993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.